March 24, 2016Current Drug Metabolism

Diabetic Nephropathy: Focus on Current and Future Therapeutic Strategies

View Full Paper

Ask AI

Bookmark

Population

Patients with diabetic nephropathy

Design

Review

Authors

RPRiccardo PofiChurchill Hospital FMFrancesca Di MarioOspedale di Parma AGAntonietta GiganteQueen Mary University of London

Discussion

Member takes

Implication

ACE inhibitors offer limited renoprotection in diabetic kidney disease; leaves open the value of novel strategies pending prospective trials.

Structured PICO

Population

Patients with diabetic nephropathy

Intervention

Current and novel therapeutic strategies including lifestyle changes, blood pressure monitoring, tight glycemic control, and ACE-inhibitors

Outcome

Progression of renal damage to end-stage renal disease (ESRD)

This review highlights the limitations of current therapies like ACE inhibitors in preventing ESRD in diabetic nephropathy and summarizes novel therapeutic strategies.

Cite This Study

Pofi et al. (2016) studied this question.

synapsesocial.com/papers/6a0c94cae28175e95a2369ea https://doi.org/10.2174/138920021705160324165553

View Full Paper

Ask AI

Bookmark

Implication

ACE inhibitors offer limited renoprotection in diabetic kidney disease; leaves open the value of novel strategies pending prospective trials.

Diabetic Nephropathy: Focus on Current and Future Therapeutic Strategies

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Diabetic Nephropathy: Focus on Current and Future Therapeutic Strategies

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Also Consider